Allylamine

Allylamine

SCHEMBL3842065

C=CCN.C=CCN.C=CCN.C=CCN.F[B-](F)(F)F

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Allylamine SCHEMBL27555105 0.96
Allylamine SCHEMBL15197 0.83
Allylamine SCHEMBL6032547 0.83
Allylamine SCHEMBL11114361 0.80
Allylamine SCHEMBL169953 0.79
Allylamine SCHEMBL11373125 0.79
Allylamine SCHEMBL8858077 0.79 ALDH1A1 (0.90) ALDH1A1
Allylamine SCHEMBL13256599 0.79
Allylamine SCHEMBL5891273 0.79
Allylamine SCHEMBL3883129 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367220-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 US disclosed
US-8367219-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 US disclosed
US-20090166670-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-07-02 US disclosed
EP-2055702-A1 Anthracene-based compound and organic light emitting device employing the same Samsung Electronics Co., Ltd. (KR) 2009-05-06 EP disclosed
US-20090108746-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090166670-A1 Anthracene-based compound and organic light emitting device employing the same CCNL2, CRY2, ATXN2L ALDH1A1 1133/4885
US-20090108746-A1 Anthracene-based compound and organic light emitting device employing the same CCNL2, CRY2, ATXN2L ALDH1A1 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.